Status:
UNKNOWN
Heart Failure After Heart Transplantation Due to Chronic Rejection
Lead Sponsor:
Sahlgrenska University Hospital
Conditions:
Cardiac Allograft Vasculopathy
Chronic Rejection of Cardiac Transplant
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will investigate the prevalence of allograft vasculopathy and unexplained graft dysfunction during long-term follow-up after heart transplantation. Risk factors as well diagnostic approache...
Detailed Description
During long-term follow-up heart transplant recipients are at risk of developing different complications that are likely to affect quality of life and survival. The most common cause of death during t...
Eligibility Criteria
Inclusion
- Heart transplant performed more than 10 years and less than 21 years ago
- Scheduled yearly post-transplant control
- Signed informed consent
Exclusion
- Estimated GFR \< 30 mL/min/1,73m2
- Radiographic contrast allergy
- Severe asthma or COLD with FEV1 \< 50%
- Second or third degree AV block
- Pregnancy
- In the Investigator's opinion, the patient has a clinically significant disease that could be adversely affected by study participation
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03808324
Start Date
January 1 2019
End Date
March 1 2021
Last Update
January 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sahlgrenska University Hospital
Gothenburg, Sweden, 413 45